⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1415925 | 0.98 | KDM4E (0.42) | — | |
| SCHEMBL1416651 | 0.92 | — | — | |
| SCHEMBL1837224 | 0.87 | KDM4E (0.48) | — | |
| SCHEMBL1837168 | 0.84 | KDM4E (0.52) | — | |
| SCHEMBL28622543 | 0.84 | KDM4E (0.52) | — | |
| SCHEMBL11180722 | 0.84 | KDM4E (0.52) | — | |
| SCHEMBL11173620 | 0.84 | KDM4E (0.52) | — | |
| SCHEMBL28560371 | 0.84 | KDM4E (0.52) | — | |
| SCHEMBL1309360 | 0.84 | KDM4E (0.52) | — | |
| SCHEMBL1839119 | 0.84 | KDM4E (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117777236-A | Labeled targeting agents for diagnosing or treating somatostatin receptor expression | 南京医科大学 | 2024-03-29 | — | — | CN | claimed |
| CN-117777236-A | Labeled targeting agents for diagnosing or treating somatostatin receptor expression | 南京医科大学 | 2024-03-29 | — | — | CN | disclosed |
| US-11583509-B2 | Compound for treating cancer and diabetes | CITY OF HOPE (US) | 2023-02-21 | — | — | US | disclosed |
| US-20220023240-A1 | COMPOUND FOR TREATING CANCER AND DIABETES | CITY OF HOPE | 2022-01-27 | — | — | US | disclosed |
| EP-3830093-A1 | BIFUNCTIONAL COMPOUNDS AS CDK MODULATORS | Biotheryx, Inc. (US) | 2021-06-09 | — | — | EP | disclosed |
| US-10588854-B2 | Polymer implants for treatment of metabolic disorders | UNIVERSITY OF SOUTH CAROLINA (US) | 2020-03-17 | — | — | US | disclosed |
| WO-2020023782-A1 | BIFUNCTIONAL COMPOUNDS AS CDK MODULATORS | BIOTHERYX, INC. (US) | 2020-01-30 | — | — | WO | disclosed |
| US-20190000749-A1 | Polymer Implants for Treatment of Metabolic Disorders | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2019-01-03 | — | — | US | disclosed |
| US-10092508-B2 | Polymer implants for treatment of metabolic disorders | UNIVERSITY OF SOUTH CAROLINA (US) | 2018-10-09 | — | — | US | disclosed |
| US-10029991-B2 | Modulators of development of adipocyte and cancer cells | CITY OF HOPE (US) | 2018-07-24 | — | — | US | disclosed |
| US-4088815-A | BACTERICIDES | E. R. SQUIBB & SONS, INC. (US) | 1978-05-09 | — | — | US | disclosed |
| US-4088816-A | BACTERICIDES | E. R. SQUIBB & SONS, INC. (US) | 1978-05-09 | — | — | US | disclosed |
| US-4086422-A | BACTERICIDES | E. R. SQUIBB & SONS, INC. (US) | 1978-04-25 | — | — | US | disclosed |
| US-4063019-A | BACTERICIDE | E. R. SQUIBB & SONS, INC. (US) | 1977-12-13 | — | — | US | disclosed |
| US-4052554-A | BACTERICIDE | E. R. SQUIBB & SONS, INC. (US) | 1977-10-04 | — | — | US | disclosed |
| US-4049651-A | Alkoxy and alkylthioalkylureido cephalosporins | E. R. SQUIBB & SONS, INC. (US) | 1977-09-20 | — | — | US | disclosed |
| US-4028354-A | BACTERICIDES | E. R. SQUIBB & SONS, INC. (US) | 1977-06-07 | — | — | US | disclosed |
| US-4024135-A | ANTIBACTERIAL | E. R. SQUIBB & SONS, INC. (US) | 1977-05-17 | — | — | US | disclosed |
| US-3996217-A | BACTERICIDES | E. R. SQUIBB & SONS, INC. (US) | 1976-12-07 | — | — | US | disclosed |
| US-3996218-A | BACTERICIDES | E. R. SQUIBB & SONS, INC. (US) | 1976-12-07 | — | — | US | disclosed |